99 related articles for article (PubMed ID: 22964467)
1. Prostaglandin E2 receptor subtypes in human blood and vascular cells.
Foudi N; Gomez I; Benyahia C; Longrois D; Norel X
Eur J Pharmacol; 2012 Nov; 695(1-3):1-6. PubMed ID: 22964467
[TBL] [Abstract][Full Text] [Related]
2. Prostanoid receptors in the human vascular wall.
Norel X
ScientificWorldJournal; 2007 Sep; 7():1359-74. PubMed ID: 17767355
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-kappaB.
Gómez-Hernández A; Martín-Ventura JL; Sánchez-Galán E; Vidal C; Ortego M; Blanco-Colio LM; Ortega L; Tuñón J; Egido J
Atherosclerosis; 2006 Jul; 187(1):139-49. PubMed ID: 16212965
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
Schweda F; Klar J; Narumiya S; Nüsing RM; Kurtz A
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F427-33. PubMed ID: 15113745
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes.
Richards JA; Brueggemeier RW
J Clin Endocrinol Metab; 2003 Jun; 88(6):2810-6. PubMed ID: 12788892
[TBL] [Abstract][Full Text] [Related]
6. E-Ring Isoprostanes Stimulate a Cl Conductance in Airway Epithelium via Prostaglandin E2-Selective Prostanoid Receptors.
Seto V; Hirota C; Hirota S; Janssen LJ
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):88-94. PubMed ID: 17673688
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E receptors and the kidney.
Breyer MD; Breyer RM
Am J Physiol Renal Physiol; 2000 Jul; 279(1):F12-23. PubMed ID: 10894784
[TBL] [Abstract][Full Text] [Related]
8. Roles of EP Receptors in the Regulation of Fluid Balance and Blood Pressure.
Wang L; Wu Y; Jia Z; Yu J; Huang S
Front Endocrinol (Lausanne); 2022; 13():875425. PubMed ID: 35813612
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E₂ induced contraction of human intercostal arteries is mediated by the EP₃ receptor.
Longrois D; Gomez I; Foudi N; Topal G; Dhaouadi M; Kotelevets L; Chastre E; Norel X
Eur J Pharmacol; 2012 Apr; 681(1-3):55-9. PubMed ID: 22342278
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the human prostanoid TPalpha and TPbeta receptor isoforms mediated through activation of the EP(1) and IP receptors.
Walsh MT; Kinsella BT
Br J Pharmacol; 2000 Oct; 131(3):601-9. PubMed ID: 11015313
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2-derived prostaglandin E2 is involved in vascular endothelial growth factor production in interleukin-1alpha-stimulated human periodontal ligament cells.
Bando Y; Noguchi K; Kobayashi H; Yoshida N; Ishikawa I; Izumi Y
J Periodontal Res; 2009 Jun; 44(3):395-401. PubMed ID: 19210337
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.
Dey I; Lejeune M; Chadee K
Br J Pharmacol; 2006 Nov; 149(6):611-23. PubMed ID: 17016496
[TBL] [Abstract][Full Text] [Related]
14. Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes.
Wilson RJ; Giles H
Br J Pharmacol; 2005 Feb; 144(3):405-15. PubMed ID: 15655509
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E receptors as inflammatory therapeutic targets for atherosclerosis.
Yang C; Liu X; Cao Q; Liang Q; Qiu X
Life Sci; 2011 Jan; 88(5-6):201-5. PubMed ID: 21112342
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E receptors in bile ducts of hepatolithiasis patients and the pathobiological significance for cholangitis.
Shoda J; Ueda T; Kawamoto T; Todoroki T; Asano T; Sugimoto Y; Ichikawa A; Maruyama T; Nimura Y; Tanaka N
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):285-96. PubMed ID: 15017670
[TBL] [Abstract][Full Text] [Related]
17. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
Walch L; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
[TBL] [Abstract][Full Text] [Related]
18. Novel prostaglandin receptor modulators--part II: EP receptor modulators; a patent review (2002 - 2012).
Flesch D; Merk D; Lamers C; Schubert-Zsilavecz M
Expert Opin Ther Pat; 2013 Feb; 23(2):233-67. PubMed ID: 23289354
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of activated beta1-integrin expression by prostaglandin E2 via EP receptors in isolated human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease.
Kajimoto M; Ichiyama T; Ueno Y; Shiraishi M; Hasegawa M; Furukawa S
Inflamm Res; 2009 Apr; 58(4):224-8. PubMed ID: 19169646
[TBL] [Abstract][Full Text] [Related]
20. Functional pharmacology of human prostanoid EP2 and EP4 receptors.
Wilson RJ; Rhodes SA; Wood RL; Shield VJ; Noel LS; Gray DW; Giles H
Eur J Pharmacol; 2004 Oct; 501(1-3):49-58. PubMed ID: 15464062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
